Biomarker for Colorectal Cancer - Licensing Opportunity from Trinity College Dublin - July 2015 front page preview

Biomarker for Colorectal Cancer - Licensing Opportunity from Trinity College Dublin - July 2015

The pathogenesis of 15% of human cancers has been linked to inflammation. One of the most prevalent inflammation driven cancers is colitis-associated colorectal cancer (CRC). Annually Ireland - CRC is responsible for 15%...

pdf 1MB

Dissolution Simulation - Licensing Opportunity from Trinity College Dublin - July 2015 front page preview

Dissolution Simulation - Licensing Opportunity from Trinity College Dublin - July 2015

This software code allows generation of a simulated profile of particles dissolving over time. It includes simulation of dissolution under a range of pharmaceutical industry-standard test conditions.

pdf 1.1MB

Cartilage Repair Therapy - Licensing Opportunity from Trinity College Dublin - July 2015 front page preview

Cartilage Repair Therapy - Licensing Opportunity from Trinity College Dublin - July 2015

Articular cartilage injury or degeneration is a common disorder of joints, affecting people of all ages. More than 500,000 cartilage repair procedures are performed annually in the United States alone. The intrinsic rang...

pdf 1.1MB

Novel Biomarker for Multiple Myeloma Diagnosis and Prognosis - Licensing Opportunity from National University of Ireland Galway - March 2015 front page preview

Novel Biomarker for Multiple Myeloma Diagnosis and Prognosis - Licensing Opportunity from National University of Ireland Galway - March 2015

Multiple Myeloma is a highly prevalent disease accounting for 1-2% of all cancers, with a market size for treatments estimated to grow to $7 billion by 2020. This technology will prove to be extremely valuable in fightin...

pdf 1.2MB

Novel Marker for the Isolation of Pure Mesenchymal Stem Cell populations - Licensing Opportunity from National University of Ireland Galway - March 2015 front page preview

Novel Marker for the Isolation of Pure Mesenchymal Stem Cell populations - Licensing Opportunity from National University of Ireland Galway - March 2015

MSCs are being developed to treat a host of human diseases, however they are present in extremely small numbers in the body. This technology allows for the effective and efficient isolation and purification of these rare...

pdf 1.2MB